Logo

Rick Klausner, Tristan Orpin, and more

Dec 10, 2015

Illumina has announced the following changes to its management structure:

  • Rick Klausner, chief opportunity officer, will be leaving the company in the first quarter of 2016.

  • Tristan Orpin has been promoted to executive vice president of clinical genomics.

  • Omead Ostadan has been promoted to executive vice president of operations, products, and strategy.

  • Marc Stapley has been promoted to executive vice president and chief administrative officer. He will continue to act as chief financial officer until a replacement has been appointed.

  • Christian Henry has been promoted to executive vice president and chief commercial officer.